← Open Payments lookup

ARMAN HEKMATI: Open Payments

NPI 1326080128 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,465 in 108 payments from 24 companies in 2025. Trend: 2023 $2,094 · 2024 $2,121 · 2025 $2,465

Food & beverage: $2,465
CompanyPaymentsAmount
Amgen Inc.14$330
AstraZeneca Pharmaceuticals LP12$294
Bayer Healthcare Pharmaceuticals Inc.9$214
Axsome Therapeutics, Inc.7$165
GlaxoSmithKline, LLC.8$156
Eisai Inc.7$149
Lilly USA, LLC5$133
Takeda Pharmaceuticals U.S.A., Inc.5$123
Novo Nordisk Inc4$105
Bausch Health US, LLC5$102

Products named: Kerendia, Auvelity, Leqembi, TRINTELLIX, TRELEGY ELLIPTA, Ozempic, WELLBUTRIN, REXULTI.

Industry payments across CA — which companies pay providers there.